Bipolar Ionization Research

The AutoClean 1500 achieved greater than 99.99% reduction of active SARS-CoV-2 USA-CA1/2020 after 90 minutes of exposure.

Plasma Air's 603 from the 600 series was shown to reduce MS2 bacteriophage, a surrogate for SARS-CoV-2, by 99.39% in 240 minutes at Aerosol Research and Engineering Laboratories in Kansas.

Plasma Air's D5 needlepoint ionizer cartridge used in the 7000 series and Plasma BAR was shown to reduce Staphylococcus aureus (91.50%), Pseudomonas aeruginosa (99.99%), Escherichia coli (91.15%) and Bacillus subtilis var. niger (89.30%).

Plasma Air's D5 needlepoint ionizer cartridge used in the 7000 series and Plasma BAR was shown to reduce Escherichia coli (99.43%), Staphylococcus aureus (81.67%), Aspergillus niger (97.14%), Candida albicans (97.69%) and Cladosporium cladospoioides (36.27%).

Plasma Air's D5 needlepoint ionizer cartridge used in the 7000 series and Plasma BAR was shown to reduce Influenza A (H1N1) 86.6%.

Plasma Air's D5 needlepoint ionizer used in the 7000 Series and Plasma BAR was shown to reduce Dichobotrys abundans (90%) and Penicillium (95%) in a typical residential setting.

Home Creations has dedicated itself to building new homes in Oklahoma that offer the latest in amenities, design and location at an unbeatable value. And in May 2020, they began installing Plasma Air 600 Series units in every new home built.

Plasma Air’s PlasmaSoft™ helps Atlas Design & Engineering Inc. reduce outside air intake and associated equipment costs in client buildings.

Plasma Air HVAC Needlepoint Technology treats almost 80,000 CFM supply exceeding IAQ expectations with little to no maintenance costs.

Air quality assessment to validate performance.

Plasma Air cleans and reduces outside air for new VRF system at Virtua Center for Weight Loss.

Plasma Air 600 Series demonstrates improvement in indoor air quality by reducing VOCs and virus size particles.